APO Research
Talk to an analyst

APO RESEARCH · REPORT

Synthetic Opioids

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Synthetic Opioids Industry Growth and Trends Forecast to 2032

20 December 2025104 pages

Choose your research edition.

Industry ResearchSynthetic Opioids Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Synthetic Opioids Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Synthetic Opioids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Synthetic Opioids Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Synthetic Opioids Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Synthetic Opioids market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Synthetic Opioids is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Synthetic Opioids is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Synthetic Opioids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Synthetic Opioids include Endo International, Impax Laboratories, Indivior, Janssen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Purdue Pharma, West-Ward Pharmaceuticals, Pfizer and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Synthetic Opioids market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Synthetic Opioids market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Synthetic Opioids market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Synthetic Opioids.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Synthetic Opioids market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Synthetic Opioids Market by Company

Endo International

Impax Laboratories

Indivior

Janssen Pharmaceuticals

Mallinckrodt Pharmaceuticals

Purdue Pharma

West-Ward Pharmaceuticals

Pfizer

Mylan

Teva Pharmaceuticals

Synthetic Opioids Segment by Type

Hydrocodone

Oxymorphone

Oxycodone

Meperidine

Methadone

Fentanyl

Synthetic Opioids Segment by Application

Pain Management

De-addiction

Synthetic Opioids Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synthetic Opioids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Synthetic Opioids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synthetic Opioids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Synthetic Opioids manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Synthetic Opioids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hydrocodone Table 2. Major Company of Oxymorphone Table 3. Major Company of Oxycodone Table 4. Major Company of Meperidine Table 5. Major Company of Methadone Table 6. Major Company of Fentanyl Table 7. Global Synthetic Opioids Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Synthetic Opioids Sales by Type (2021-2026) & (K Units) Table 9. Global Synthetic Opioids Sales Market Share in Volume by Type (2021-2026) Table 10. Global Synthetic Opioids Sales by Type (2021-2026) & (US$ Million) Table 11. Global Synthetic Opioids Sales Market Share in Value by Type (2021-2026) Table 12. Global Synthetic Opioids Price by Type (2021-2026) & (US$/Unit) Table 13. Global Synthetic Opioids Sales by Type (2027-2032) & (K Units) Table 14. Global Synthetic Opioids Sales Market Share in Volume by Type (2027-2032) Table 15. Global Synthetic Opioids Sales by Type (2027-2032) & (US$ Million) Table 16. Global Synthetic Opioids Sales Market Share in Value by Type (2027-2032) Table 17. Global Synthetic Opioids Price by Type (2027-2032) & (US$/Unit) Table 18. North America Synthetic Opioids Sales by Type (2021-2026) & (K Units) Table 19. North America Synthetic Opioids Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Synthetic Opioids Sales by Type (2021-2026) & (K Units) Table 21. Europe Synthetic Opioids Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Synthetic Opioids Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Synthetic Opioids Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Synthetic Opioids Sales by Type (2021-2026) & (K Units) Table 25. Latin America Synthetic Opioids Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Synthetic Opioids Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Synthetic Opioids Sales by Type (2021-2026) & (US$ Million) Table 28. Synthetic Opioids Industry Trends Table 29. Synthetic Opioids Industry Drivers Table 30. Synthetic Opioids Industry Opportunities and Challenges Table 31. Synthetic Opioids Industry Restraints Table 32. Global Synthetic Opioids Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Synthetic Opioids Revenue Market Share by Company (2021-2026) Table 34. Global Synthetic Opioids Sales by Company (2021-2026) & (K Units) Table 35. Global Synthetic Opioids Sales Share by Company (2021-2026) Table 36. Global Synthetic Opioids Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Synthetic Opioids Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Synthetic Opioids Major Company Production Sites and Headquarters Table 39. Global Synthetic Opioids Company, Product Type & Application Table 40. Global Synthetic Opioids Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Synthetic Opioids by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Synthetic Opioids Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Synthetic Opioids Sales by Region (2021-2026) & (K Units) Table 45. Global Synthetic Opioids Sales Market Share in Volume by Region (2021-2026) Table 46. Global Synthetic Opioids Sales by Region (2021-2026) & (US$ Million) Table 47. Global Synthetic Opioids Sales Market Share in Value by Region (2021-2026) Table 48. Global Synthetic Opioids Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Synthetic Opioids Sales by Region (2027-2032) & (K Units) Table 50. Global Synthetic Opioids Sales Market Share in Volume by Region (2027-2032) Table 51. Global Synthetic Opioids Sales by Region (2027-2032) & (US$ Million) Table 52. Global Synthetic Opioids Sales Market Share in Value by Region (2027-2032) Table 53. Global Synthetic Opioids Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Synthetic Opioids Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Synthetic Opioids Sales by Application (2021-2026) & (K Units) Table 56. Global Synthetic Opioids Sales Market Share in Volume by Application (2021-2026) Table 57. Global Synthetic Opioids Sales by Application (2021-2026) & (US$ Million) Table 58. Global Synthetic Opioids Sales Market Share in Value by Application (2021-2026) Table 59. Global Synthetic Opioids Price by Application (2021-2026) & (US$/Unit) Table 60. Global Synthetic Opioids Sales by Application (2027-2032) & (K Units) Table 61. Global Synthetic Opioids Sales Market Share in Volume by Application (2027-2032) Table 62. Global Synthetic Opioids Sales by Application (2027-2032) & (US$ Million) Table 63. Global Synthetic Opioids Sales Market Share in Value by Application (2027-2032) Table 64. Global Synthetic Opioids Price by Application (2027-2032) & (US$/Unit) Table 65. North America Synthetic Opioids Sales by Application (2021-2026) & (K Units) Table 66. North America Synthetic Opioids Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Synthetic Opioids Sales by Application (2021-2026) & (K Units) Table 68. Europe Synthetic Opioids Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Synthetic Opioids Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Synthetic Opioids Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Synthetic Opioids Sales by Application (2021-2026) & (K Units) Table 72. Latin America Synthetic Opioids Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Synthetic Opioids Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Synthetic Opioids Sales by Application (2021-2026) & (US$ Million) Table 75. Endo International Company Information Table 76. Endo International Business Overview Table 77. Endo International Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Endo International Synthetic Opioids Product Portfolio Table 79. Endo International Recent Development Table 80. Impax Laboratories Company Information Table 81. Impax Laboratories Business Overview Table 82. Impax Laboratories Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Impax Laboratories Synthetic Opioids Product Portfolio Table 84. Impax Laboratories Recent Development Table 85. Indivior Company Information Table 86. Indivior Business Overview Table 87. Indivior Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Indivior Synthetic Opioids Product Portfolio Table 89. Indivior Recent Development Table 90. Janssen Pharmaceuticals Company Information Table 91. Janssen Pharmaceuticals Business Overview Table 92. Janssen Pharmaceuticals Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Janssen Pharmaceuticals Synthetic Opioids Product Portfolio Table 94. Janssen Pharmaceuticals Recent Development Table 95. Mallinckrodt Pharmaceuticals Company Information Table 96. Mallinckrodt Pharmaceuticals Business Overview Table 97. Mallinckrodt Pharmaceuticals Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Mallinckrodt Pharmaceuticals Synthetic Opioids Product Portfolio Table 99. Mallinckrodt Pharmaceuticals Recent Development Table 100. Purdue Pharma Company Information Table 101. Purdue Pharma Business Overview Table 102. Purdue Pharma Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Purdue Pharma Synthetic Opioids Product Portfolio Table 104. Purdue Pharma Recent Development Table 105. West-Ward Pharmaceuticals Company Information Table 106. West-Ward Pharmaceuticals Business Overview Table 107. West-Ward Pharmaceuticals Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. West-Ward Pharmaceuticals Synthetic Opioids Product Portfolio Table 109. West-Ward Pharmaceuticals Recent Development Table 110. Pfizer Company Information Table 111. Pfizer Business Overview Table 112. Pfizer Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Pfizer Synthetic Opioids Product Portfolio Table 114. Pfizer Recent Development Table 115. Mylan Company Information Table 116. Mylan Business Overview Table 117. Mylan Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Mylan Synthetic Opioids Product Portfolio Table 119. Mylan Recent Development Table 120. Teva Pharmaceuticals Company Information Table 121. Teva Pharmaceuticals Business Overview Table 122. Teva Pharmaceuticals Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Teva Pharmaceuticals Synthetic Opioids Product Portfolio Table 124. Teva Pharmaceuticals Recent Development Table 125. North America Synthetic Opioids Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 126. North America Synthetic Opioids Sales by Country (2021-2026) & (K Units) Table 127. North America Synthetic Opioids Sales Market Share by Country (2021-2026) Table 128. North America Synthetic Opioids Sales Forecast by Country (2027-2032) & (K Units) Table 129. North America Synthetic Opioids Sales Market Share Forecast by Country (2027-2032) Table 130. North America Synthetic Opioids Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. North America Synthetic Opioids Market Size by Country (2021-2026) & (US$ Million) Table 132. North America Synthetic Opioids Market Share by Country (2021-2026) Table 133. North America Synthetic Opioids Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. North America Synthetic Opioids Market Share Forecast by Country (2027-2032) Table 135. Europe Synthetic Opioids Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 136. Europe Synthetic Opioids Sales by Country (2021-2026) & (K Units) Table 137. Europe Synthetic Opioids Sales Market Share by Country (2021-2026) Table 138. Europe Synthetic Opioids Sales Forecast by Country (2027-2032) & (K Units) Table 139. Europe Synthetic Opioids Sales Market Share Forecast by Country (2027-2032) Table 140. Europe Synthetic Opioids Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Europe Synthetic Opioids Market Size by Country (2021-2026) & (US$ Million) Table 142. Europe Synthetic Opioids Market Share by Country (2021-2026) Table 143. Europe Synthetic Opioids Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Europe Synthetic Opioids Market Share Forecast by Country (2027-2032) Table 145. Asia-Pacific Synthetic Opioids Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. Asia-Pacific Synthetic Opioids Sales by Country (2021-2026) & (K Units) Table 147. Asia-Pacific Synthetic Opioids Sales Market Share by Country (2021-2026) Table 148. Asia-Pacific Synthetic Opioids Sales Forecast by Country (2027-2032) & (K Units) Table 149. Asia-Pacific Synthetic Opioids Sales Market Share Forecast by Country (2027-2032) Table 150. Asia-Pacific Synthetic Opioids Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Asia-Pacific Synthetic Opioids Market Size by Country (2021-2026) & (US$ Million) Table 152. Asia-Pacific Synthetic Opioids Market Share by Country (2021-2026) Table 153. Asia-Pacific Synthetic Opioids Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Asia-Pacific Synthetic Opioids Market Share Forecast by Country (2027-2032) Table 155. Latin America Synthetic Opioids Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 156. Latin America Synthetic Opioids Sales by Country (2021-2026) & (K Units) Table 157. Latin America Synthetic Opioids Sales Market Share by Country (2021-2026) Table 158. Latin America Synthetic Opioids Sales Forecast by Country (2027-2032) & (K Units) Table 159. Latin America Synthetic Opioids Sales Market Share Forecast by Country (2027-2032) Table 160. Latin America Synthetic Opioids Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Latin America Synthetic Opioids Market Size by Country (2021-2026) & (US$ Million) Table 162. Latin America Synthetic Opioids Market Share by Country (2021-2026) Table 163. Latin America Synthetic Opioids Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Latin America Synthetic Opioids Market Share Forecast by Country (2027-2032) Table 165. Middle East and Africa Synthetic Opioids Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 166. Middle East and Africa Synthetic Opioids Sales by Country (2021-2026) & (K Units) Table 167. Middle East and Africa Synthetic Opioids Sales Market Share by Country (2021-2026) Table 168. Middle East and Africa Synthetic Opioids Sales Forecast by Country (2027-2032) & (K Units) Table 169. Middle East and Africa Synthetic Opioids Sales Market Share Forecast by Country (2027-2032) Table 170. Middle East and Africa Synthetic Opioids Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Middle East and Africa Synthetic Opioids Market Size by Country (2021-2026) & (US$ Million) Table 172. Middle East and Africa Synthetic Opioids Market Share by Country (2021-2026) Table 173. Middle East and Africa Synthetic Opioids Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Middle East and Africa Synthetic Opioids Market Share Forecast by Country (2027-2032) Table 175. Key Raw Materials Table 176. Raw Materials Key Suppliers Table 177. Synthetic Opioids Distributors List Table 178. Synthetic Opioids Customers List Table 179. Research Programs/Design for This Report Table 180. Authors List of This Report Table 181. Secondary Sources Table 182. Primary Sources List of Figures Figure 1. Synthetic Opioids Image Figure 2. Global Synthetic Opioids Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Synthetic Opioids Market Size (2021-2032) & (US$ Million) Figure 4. Global Synthetic Opioids Sales (2021-2032) & (K Units) Figure 5. Hydrocodone Image Figure 6. Global Hydrocodone Sales YoY Growth (2021-2032) & (K Units) Figure 7. Oxymorphone Image Figure 8. Global Oxymorphone Sales YoY Growth (2021-2032) & (K Units) Figure 9. Oxycodone Image Figure 10. Global Oxycodone Sales YoY Growth (2021-2032) & (K Units) Figure 11. Meperidine Image Figure 12. Global Meperidine Sales YoY Growth (2021-2032) & (K Units) Figure 13. Methadone Image Figure 14. Global Methadone Sales YoY Growth (2021-2032) & (K Units) Figure 15. Fentanyl Image Figure 16. Global Fentanyl Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Synthetic Opioids Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Synthetic Opioids Market Share by Type 2025 VS 2032 Figure 19. North America Synthetic Opioids Sales Market Share in Volume by Type in 2025 Figure 20. North America Synthetic Opioids Sales Market Share in Value by Type in 2025 Figure 21. Europe Synthetic Opioids Sales Market Share in Volume by Type in 2025 Figure 22. Europe Synthetic Opioids Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Synthetic Opioids Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Synthetic Opioids Sales Market Share in Value by Type in 2025 Figure 25. Latin America Synthetic Opioids Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Synthetic Opioids Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Synthetic Opioids Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Synthetic Opioids Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Synthetic Opioids Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Pain Management Image Figure 32. Global Pain Management Sales YoY Growth (2021-2032) & (K Units) Figure 33. De-addiction Image Figure 34. Global De-addiction Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Synthetic Opioids Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Synthetic Opioids Market Share by Application 2025 VS 2032 Figure 37. North America Synthetic Opioids Sales Market Share in Volume by Application in 2025 Figure 38. North America Synthetic Opioids Sales Market Share in Value by Application in 2025 Figure 39. Europe Synthetic Opioids Sales Market Share in Volume by Application in 2025 Figure 40. Europe Synthetic Opioids Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Synthetic Opioids Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Synthetic Opioids Sales Market Share in Value by Application in 2025 Figure 43. Latin America Synthetic Opioids Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Synthetic Opioids Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Synthetic Opioids Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Synthetic Opioids Sales Market Share in Value by Application in 2025 Figure 47. North America Synthetic Opioids Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Synthetic Opioids Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Synthetic Opioids Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Synthetic Opioids Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Synthetic Opioids Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Synthetic Opioids Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Synthetic Opioids Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Synthetic Opioids Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Synthetic Opioids Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Synthetic Opioids Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Synthetic Opioids Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Synthetic Opioids Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Synthetic Opioids Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Synthetic Opioids Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Synthetic Opioids Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Synthetic Opioids Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Synthetic Opioids Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Synthetic Opioids Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Synthetic Opioids Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Synthetic Opioids Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Synthetic Opioids Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Synthetic Opioids Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Hydrocodone
  • Oxymorphone
  • Oxycodone
  • Meperidine
  • Methadone
  • Fentanyl
Applications
  • Pain Management
  • De-addiction
Companies covered
  • Endo International
  • Impax Laboratories
  • Indivior
  • Janssen Pharmaceuticals
  • Mallinckrodt Pharmaceuticals
  • Purdue Pharma
  • West-Ward Pharmaceuticals
  • Pfizer
  • Mylan
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Synthetic Opioids Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Synthetic Opioids Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Synthetic Opioids Market by Type
  6. 1.3.1 Hydrocodone
  7. 1.3.2 Oxymorphone
  8. 1.3.3 Oxycodone
  9. 1.3.4 Meperidine
  10. 1.3.5 Methadone
  11. 1.3.6 Fentanyl
  12. 1.4 Global Synthetic Opioids Market Size by Type
  13. 1.4.1 Global Synthetic Opioids Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Synthetic Opioids Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Synthetic Opioids Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Synthetic Opioids Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Synthetic Opioids Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Synthetic Opioids Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Synthetic Opioids Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Synthetic Opioids Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Synthetic Opioids Industry Trends
  2. 2.2 Synthetic Opioids Industry Drivers
  3. 2.3 Synthetic Opioids Industry Opportunities and Challenges
  4. 2.4 Synthetic Opioids Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Synthetic Opioids Revenue (2021-2026)
  2. 3.2 Global Top Players by Synthetic Opioids Sales (2021-2026)
  3. 3.3 Global Top Players by Synthetic Opioids Price (2021-2026)
  4. 3.4 Global Synthetic Opioids Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Synthetic Opioids Major Company Production Sites & Headquarters
  6. 3.6 Global Synthetic Opioids Company, Product Type & Application
  7. 3.7 Global Synthetic Opioids Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Synthetic Opioids Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Synthetic Opioids Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Synthetic Opioids Tier 1, Tier 2, and Tier 3
4 Synthetic Opioids Regional Status and Outlook
  1. 4.1 Global Synthetic Opioids Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Synthetic Opioids Historic Market Size by Region
  3. 4.2.1 Global Synthetic Opioids Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Synthetic Opioids Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Synthetic Opioids Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Synthetic Opioids Forecasted Market Size by Region
  7. 4.3.1 Global Synthetic Opioids Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Synthetic Opioids Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Synthetic Opioids Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Synthetic Opioids by Application
  1. 5.1 Synthetic Opioids Market by Application
  2. 5.1.1 Pain Management
  3. 5.1.2 De-addiction
  4. 5.2 Global Synthetic Opioids Market Size by Application
  5. 5.2.1 Global Synthetic Opioids Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Synthetic Opioids Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Synthetic Opioids Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Synthetic Opioids Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Synthetic Opioids Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Synthetic Opioids Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Synthetic Opioids Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Synthetic Opioids Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Endo International
  2. 6.1.1 Endo International Company Information
  3. 6.1.2 Endo International Business Overview
  4. 6.1.3 Endo International Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Endo International Synthetic Opioids Product Portfolio
  6. 6.1.5 Endo International Recent Developments
  7. 6.2 Impax Laboratories
  8. 6.2.1 Impax Laboratories Company Information
  9. 6.2.2 Impax Laboratories Business Overview
  10. 6.2.3 Impax Laboratories Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Impax Laboratories Synthetic Opioids Product Portfolio
  12. 6.2.5 Impax Laboratories Recent Developments
  13. 6.3 Indivior
  14. 6.3.1 Indivior Company Information
  15. 6.3.2 Indivior Business Overview
  16. 6.3.3 Indivior Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Indivior Synthetic Opioids Product Portfolio
  18. 6.3.5 Indivior Recent Developments
  19. 6.4 Janssen Pharmaceuticals
  20. 6.4.1 Janssen Pharmaceuticals Company Information
  21. 6.4.2 Janssen Pharmaceuticals Business Overview
  22. 6.4.3 Janssen Pharmaceuticals Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Janssen Pharmaceuticals Synthetic Opioids Product Portfolio
  24. 6.4.5 Janssen Pharmaceuticals Recent Developments
  25. 6.5 Mallinckrodt Pharmaceuticals
  26. 6.5.1 Mallinckrodt Pharmaceuticals Company Information
  27. 6.5.2 Mallinckrodt Pharmaceuticals Business Overview
  28. 6.5.3 Mallinckrodt Pharmaceuticals Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mallinckrodt Pharmaceuticals Synthetic Opioids Product Portfolio
  30. 6.5.5 Mallinckrodt Pharmaceuticals Recent Developments
  31. 6.6 Purdue Pharma
  32. 6.6.1 Purdue Pharma Company Information
  33. 6.6.2 Purdue Pharma Business Overview
  34. 6.6.3 Purdue Pharma Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Purdue Pharma Synthetic Opioids Product Portfolio
  36. 6.6.5 Purdue Pharma Recent Developments
  37. 6.7 West-Ward Pharmaceuticals
  38. 6.7.1 West-Ward Pharmaceuticals Company Information
  39. 6.7.2 West-Ward Pharmaceuticals Business Overview
  40. 6.7.3 West-Ward Pharmaceuticals Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 West-Ward Pharmaceuticals Synthetic Opioids Product Portfolio
  42. 6.7.5 West-Ward Pharmaceuticals Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Synthetic Opioids Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mylan Synthetic Opioids Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 Teva Pharmaceuticals
  56. 6.10.1 Teva Pharmaceuticals Company Information
  57. 6.10.2 Teva Pharmaceuticals Business Overview
  58. 6.10.3 Teva Pharmaceuticals Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Teva Pharmaceuticals Synthetic Opioids Product Portfolio
  60. 6.10.5 Teva Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Synthetic Opioids Sales by Country
  2. 7.1.1 North America Synthetic Opioids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Synthetic Opioids Sales by Country (2021-2026)
  4. 7.1.3 North America Synthetic Opioids Sales Forecast by Country (2027-2032)
  5. 7.2 North America Synthetic Opioids Market Size by Country
  6. 7.2.1 North America Synthetic Opioids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Synthetic Opioids Market Size by Country (2021-2026)
  8. 7.2.3 North America Synthetic Opioids Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Synthetic Opioids Sales by Country
  2. 8.1.1 Europe Synthetic Opioids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Synthetic Opioids Sales by Country (2021-2026)
  4. 8.1.3 Europe Synthetic Opioids Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Synthetic Opioids Market Size by Country
  6. 8.2.1 Europe Synthetic Opioids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Synthetic Opioids Market Size by Country (2021-2026)
  8. 8.2.3 Europe Synthetic Opioids Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Synthetic Opioids Sales by Country
  2. 9.1.1 Asia-Pacific Synthetic Opioids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Synthetic Opioids Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Synthetic Opioids Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Synthetic Opioids Market Size by Country
  6. 9.2.1 Asia-Pacific Synthetic Opioids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Synthetic Opioids Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Synthetic Opioids Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Synthetic Opioids Sales by Country
  2. 10.1.1 South America Synthetic Opioids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Synthetic Opioids Sales by Country (2021-2026)
  4. 10.1.3 South America Synthetic Opioids Sales Forecast by Country (2027-2032)
  5. 10.2 South America Synthetic Opioids Market Size by Country
  6. 10.2.1 South America Synthetic Opioids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Synthetic Opioids Market Size by Country (2021-2026)
  8. 10.2.3 South America Synthetic Opioids Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Synthetic Opioids Sales by Country
  2. 11.1.1 Middle East and Africa Synthetic Opioids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Synthetic Opioids Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Synthetic Opioids Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Synthetic Opioids Market Size by Country
  6. 11.2.1 Middle East and Africa Synthetic Opioids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Synthetic Opioids Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Synthetic Opioids Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Synthetic Opioids Value Chain Analysis
  2. 12.1.1 Synthetic Opioids Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Synthetic Opioids Production Mode & Process
  7. 12.2 Synthetic Opioids Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Synthetic Opioids Distributors
  10. 12.2.3 Synthetic Opioids Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst